Showing results (191-200 of 209) with videos related to
Sort By:
Pageof 21
Scientific Reports|March 24, 2017
Cross-neutralizing anti-HIV-1 human single chain variable fragments(scFvs) against CD4 binding site and N332 glycan identified from a recombinant phage libraryLubina Khan, Rajesh Kumar, Ramachandran Thiruvengadam, et al.Plos Pathogens|December 14, 2012
MiniCD4 microbicide prevents HIV infection of human mucosal explants and vaginal transmission of SHIV(162P3) in cynomolgus macaquesNathalie Dereuddre-Bosquet, Laurence Morellato-Castillo, Joachim Brouwers, et al.The Lancet. Infectious Diseases|December 10, 2014
Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional studySunil Suhas Solomon, Shruti H Mehta, Aylur K Srikrishnan, et al.Human Vaccines & Immunotherapeutics|August 8, 2023
A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiencesJonathan Kitonsa, Onesmus Kamacooko, Eugene Ruzagira, et al.Cell Host & Microbe|September 10, 2008
Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissuesAndrea Lisco, Christophe Vanpouille, Egor P Tchesnokov, et al.The Lancet. HIV|April 7, 2019
Integrated HIV testing, prevention, and treatment intervention for key populations in India: a cluster-randomised trialSunil S Solomon, Suniti Solomon, Allison M McFall, et al.Journal of Virology|February 21, 2014
Capacity for infectious HIV-1 virion capture differs by envelope antibody specificityPinghuang Liu, Latonya D Williams, Xiaoying Shen, et al.Journal of Hepatology|October 12, 2019
Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trialSunil Suhas Solomon, Thomas C Quinn, Suniti Solomon, et al.AIDS Research and Human Retroviruses|December 1, 2009
A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteersVadakkuppatu Devasenapathi Ramanathan, Makesh Kumar, Jayashri Mahalingam, et al.NPJ Vaccines|July 14, 2023
Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigensGregory M Martin, Rebecca A Russell, Philip Mundsperger, et al.Pageof 21